Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Cabergoline × Endocrine × Clear all

Phase

Status

Completed 4 Unknown 1 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 1

Interventions

somapacitan 1 irinotecan sucrosofate 1 PM 01183 1 Injections 1 Fluorodeoxyglucose F18 1 Diagnostic Self Evaluation 1 Carboplatin 1 Cabergoline 1 Bed Rest 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07034859 2025-06-24

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

National Taiwan University Hospital

Phase 4 Enrolling by invitation

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡